EventLecture
BIH Lecture "Current Status and Future Vision of Retinal Cell Therapy" by Dr. Masayo Takahashi
The BIH Lecture is organized in cooperation with the German Stem Cell Network (GSCN). Welcome and Introduction: Prof. Georg N. Duda (BIH Chair, BIH Regeneration and Julius Wolff Institut) Moderation: Prof. Hans Schöler (GSCN President, MPI Münster)
Meet the Speaker
Dr. Takahashi will be available for a special "Meet the Speaker" directly after the BIH Lecture. Use this great opportunity for your individual questions by simply staying online after the lecture. We look forward to your participation and a lively discussion!
Friday, 28 May 2021
12:00 – 1:00 pm | BIH Lecture
1:10 – 2:00 pm | "Meet the Speaker" mit Dr. Takahashi
BIH Lecture
In her BIH Lecture, Dr. Masayo Takahashi will talk about the current status and future vision of retinal cell therapy. In 2013 her project group at the Riken Center for Developmental Biology in Japan initiated the first human application of autologous iPS cell-derived RPE (iPSC-RPE) cells for age-related macular degeneration (AMD). In 2017, they proceeded with a clinical study using allogeneic iPSC-RPE cell transplants with matched HLA6 loci. In this trial, it was proven that if the HLA is not mismatched, the immune response can be controlled without the use of systemic immunosuppressive drugs. In January 2021, the third clinical study (Phase 2) started using iPSC-RPE started and the target diseases to RPE-impaired diseases including AMD and various degenerative diseases were expanded. Regarding the immune response, the research group of Dr. Takahashi obtained in vivo and in vitro POC on the safety and efficacy of iPSC-RPE with partial HLA-KO.
About the Speaker
Dr. Masayo Takahashi joined the RIKEN CDB as a Visiting Scientist and Team Leader of the Lab for Retinal Regeneration in 2006. In 2013, her team launched a pilot clinical study of autologous iPS cell-derived RPE cell sheets for exudative aged-related macular degeneration (AMD), and performed the first RPE cell sheet graft transplantation in September 2014. In August 2019, she started a new carrier as a president of start up company; Vision Care Inc. (VC’), that will collaborate with RIKEN and Kobe Eye Center with the ultimate goal of bringing stem cell therapies to patients.
---------------------------------------------------------------------------------------------------------------------------------------------
Registration
The Lecture will be held online via GoToMeeting. To participate in the Lecture, please register here. The registration will be open until maximal participant capacity is reached.
LogIn Information
Information
When
Friday, 28 May 2021
12:00 – 1:00 pm | BIH Lecture
1:10 – 2:00 pm | "Meet the Speaker" with Dr. Takahashi
How
via GoToMeeting
A login-link or dial-in number for the phone as well as an access code for the BIH Lecture will be provided the evening before the event.
Registration (starting shortly)
Please register here.
The registration will be open until maximal participant capacity is reached.
